Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F.S. Hodi, S.J. O'Day, D.F. McDermott, R.W. Weber, J.A. Sosman, JB Haanen, R. Gonzalez, C. Robert, D. Schadendorf, J.C. Hassel, W. Akerley, A.J.M. van den Eertwegh, J. Lutzky, P. Lorigan, J.M. Vaubel, G.P. Linette, D. Hogg, C.H. Ottensmeier, C. Lebbe, C. PeschelI. Quirt, J.I. Clark, J.D. Wolchok, J.S. Weber, J. Tian, M.J. Yellin, G.M. Nichol, A. Hoos, WJ Urba

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)711-723
JournalNew England Journal of Medicine
Volume363
Issue number8
DOIs
Publication statusPublished - 2010

Cite this

Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, JB., ... Urba, WJ. (2010). Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. New England Journal of Medicine, 363(8), 711-723. https://doi.org/10.1056/NEJMoa1003466